These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33466200)

  • 1. Optimal intervention time and risk of the activating blood and removing stasis method in acute cerebral hemorrhage patients: A randomized placebo-controlled trial.
    Ma Y; Zhang D; Lv Z; Cui Y; Fei Y; Chang T; Yu M; Lu J; Huang Q; Zhang Y; Xu P; Lan T; Wang J
    Medicine (Baltimore); 2021 Jan; 100(2):e24214. PubMed ID: 33466200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter Trial.
    Zhao Y; Cui W; Xie T; Zhao K; Li Y; Wan Y; Wang X; Li Q; Xiaoying C; Liu Z; Zhao H; Gong B; Wang R; Wu M; Wang D; Zheng Y; Chen Y; Chen Y; Guo Q; Gan C; Che F; Song L; Anderson CS; Guo J;
    Cerebrovasc Dis; 2024; 53(4):501-508. PubMed ID: 39250890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.
    Zhao AM; Qiu WR; Mao LJ; Ren JG; Xu L; Yao MJ; Bilinksi K; Chang D; Liu JX
    Trials; 2018 May; 19(1):275. PubMed ID: 29747670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of herbal medicine for acute intracerebral hemorrhage (CRRICH): a multicentre randomised controlled trial.
    Zeng L; Tang G; Wang J; Zhong J; Xia Z; Li J; Chen G; Zhang Y; Luo S; Huang G; Zhao Q; Wan Y; Chen C; Zhu K; Qiao H; Wang J; Huang T; Liu X; Zhang Q; Lin R; Li H; Gong B; Chen X; Zhou Y; Wen Z; Guo J
    BMJ Open; 2019 May; 9(5):e024932. PubMed ID: 31076468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Marquez-Romero JM; Arauz A; Ruiz-Sandoval JL; Cruz-Estrada Ede L; Huerta-Franco MR; Aguayo-Leytte G; Ruiz-Franco A; Silos H
    Trials; 2013 Mar; 14():77. PubMed ID: 23510124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
    Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
    Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
    Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
    CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
    Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
    Trials; 2015 Dec; 16():561. PubMed ID: 26654631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
    Cooperative Group for Reassessment of Defibrase
    Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of blood activating stasis removing method on prognosis of intracerebral hemorrhage patients].
    Yuan LX; Chen C; Zhang GM; Zhou L; Chen Y; Cui FY; Gao Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Feb; 35(2):174-8. PubMed ID: 25881461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of Qilong capsule in patients with ischemic stroke: A prospective, multicenter, non-randomized controlled trial.
    Lyu J; Gao Y; Wei R; Cai Y; Shen X; Zhao D; Zhao X; Xie Y; Yu H; Chai Y; Xie Y
    Phytomedicine; 2022 Sep; 104():154278. PubMed ID: 35780589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study).
    Venketasubramanian N; Chen CL; Gan RN; Chan BP; Chang HM; Tan SB; Picard D; Navarro JC; Baroque AC; Poungvarin N; Donnan GA; Bousser MG;
    Int J Stroke; 2009 Feb; 4(1):54-60. PubMed ID: 19236501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical re-evaluation of removing blood stasis therapy in treating acute intracerebral hemorrhage safety and efficacy: a protocol for a randomized, controlled, multicenter study (CRRICH Trial).
    Zeng L; Guo J; Wang J; Zhang Q; Li H; Lin R
    Springerplus; 2016; 5(1):1466. PubMed ID: 27652041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial.
    Li JY; Yuan LX; Zhang GM; Zhou L; Gao Y; Li QB; Chen C
    Chin J Integr Med; 2016 May; 22(5):328-34. PubMed ID: 27338955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).
    Steiner T; Vincent C; Morris S; Davis S; Vallejo-Torres L; Christensen MC
    J Stroke Cerebrovasc Dis; 2011; 20(4):287-94. PubMed ID: 20452785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
    Meretoja A; Churilov L; Campbell BC; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM
    Int J Stroke; 2014 Jun; 9(4):519-24. PubMed ID: 23981692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binafuxi granules in the treatment of common cold with heat syndrome based on traditional Uighur medicine: study protocol for a multicenter randomized controlled trial.
    Min J; She B; Zhang X; Mao B; Chen Y
    Trials; 2019 Mar; 20(1):187. PubMed ID: 30922355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of GABA
    Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
    Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.
    Naidech AM; Grotta J; Elm J; Janis S; Dowlatshahi D; Toyoda K; Steiner T; Mayer SA; Khanolkar P; Denlinger J; Audebert HJ; Molina C; Khatri P; Sprigg N; Vagal A; Broderick JP
    Int J Stroke; 2022 Aug; 17(7):806-809. PubMed ID: 34427473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.